
Heliyon, Год журнала: 2024, Номер 11(1), С. e41249 - e41249
Опубликована: Дек. 19, 2024
Язык: Английский
Heliyon, Год журнала: 2024, Номер 11(1), С. e41249 - e41249
Опубликована: Дек. 19, 2024
Язык: Английский
Cureus, Год журнала: 2025, Номер unknown
Опубликована: Янв. 9, 2025
Maternal immunization is a safe and effective strategy for protecting mothers infants from vaccine-preventable diseases. This systematic review evaluated the safety efficacy of various vaccines administered during pregnancy, focusing on maternal infant outcomes. A comprehensive literature search was conducted in PubMed, Scopus, Web Science to identify relevant studies. The used terms combinations such as ("maternal vaccination" OR "vaccination pregnancy") AND ("safety" "efficacy" "immunogenicity") ("influenza" "DTaP" "respiratory syncytial virus" "group B streptococcus" "COVID-19"). Boolean operators "AND" "OR" enhanced precision filtered limited results studies published 2018 2024. Eight were included after applying inclusion exclusion criteria. Influenza, diphtheria-tetanus-pertussis, respiratory virus, group streptococcus, COVID-19 are when pregnancy. These elicit robust immune responses pregnant women, with efficient transplacental antibody transfer providing passive immunity newborns. Adverse effects mostly mild moderate similar those observed nonpregnant individuals. No significant increase adverse pregnancy or neonatal outcomes associated vaccination. Most randomized controlled trials (had low risk bias, thus supporting reliability findings. However, vaccine hesitancy remains challenge, highlighting need transparent communication between healthcare providers women. Future research should focus long-term health outcomes, safety, immunogenicity diverse populations, strategies optimize timing enhance persistence. supports implementation routine vaccination programs emphasizes importance addressing knowledge gaps ensuring equitable access
Язык: Английский
Процитировано
0The Pediatric Infectious Disease Journal, Год журнала: 2025, Номер 44(2S), С. S18 - S22
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Vaccine, Год журнала: 2025, Номер 51, С. 126894 - 126894
Опубликована: Фев. 18, 2025
Язык: Английский
Процитировано
0Revue Francophone des Laboratoires, Год журнала: 2024, Номер 2024(562), С. 10 - 10
Опубликована: Май 1, 2024
Процитировано
1Clinical Obstetrics & Gynecology, Год журнала: 2024, Номер 67(3), С. 605 - 619
Опубликована: Июнь 20, 2024
Maternal vaccines during pregnancy offer crucial protection against infections for both the pregnant person and their newborn. Vaccines influenza, pertussis, coronavirus disease 2019, respiratory syncytial virus are routinely recommended by Centers Disease Control Prevention to safeguard women infants from potentially severe complications. Administering these helps transfer protective antibodies mother baby, enhancing immunity vulnerable early months of life. Extensive research supports safety efficacy maternal vaccines, with numerous studies demonstrating benefits people newborns.
Язык: Английский
Процитировано
1Clinics in Perinatology, Год журнала: 2024, Номер 52(1), С. 101 - 113
Опубликована: Ноя. 22, 2024
Язык: Английский
Процитировано
1Seminars in Perinatology, Год журнала: 2024, Номер 48(4), С. 151922 - 151922
Опубликована: Июнь 1, 2024
Язык: Английский
Процитировано
0Clinical Obstetrics & Gynecology, Год журнала: 2024, Номер 67(3), С. 565 - 575
Опубликована: Июль 5, 2024
In this review, we will discuss the risks of COVID-19 on maternal, obstetric, and neonatal outcomes. We also review safety vaccination in pregnancy, as well management pregnancy.
Язык: Английский
Процитировано
0Vaccines, Год журнала: 2024, Номер 12(9), С. 989 - 989
Опубликована: Авг. 29, 2024
At the beginning of coronavirus disease 2019 (COVID-19) pandemic, persons ≥65 years age and healthcare personnel represented most vulnerable groups with respect to risk infection, severe illness, death. However, as pandemic progressed, there was an increasingly detrimental effect on young children adolescents. Severe hospitalization increased over time in pediatric populations, containment measures created substantial psychosocial, educational, economic challenges for people. Vaccination against COVID-19 has been shown reduce acute respiratory syndrome 2 (SARS-CoV-2) infections outcomes populations may also help prevent spread variants concern improve community immunity. This review discusses burden throughout role transmission, impact vaccination.
Язык: Английский
Процитировано
0Heliyon, Год журнала: 2024, Номер 11(1), С. e41249 - e41249
Опубликована: Дек. 19, 2024
Язык: Английский
Процитировано
0